GLPwatch
Trials (2081)
Page 3 of 35.
- Liraglutide In Overweight Patients With Type 1 Diabetes
- A Study of LY3457263 in Obese Participants
- A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
- Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
- Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
- Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
- Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Tirzepatide in Idiopathic Intracranial Hypertension Trial
- Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
- Safety and Efficacy of Exenatide as Monotherapy
- A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
- Mechanisms of Semaglutide Therapy in Heart Failure Patients
- A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
- Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
- The Lira Pump Trial
- Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes
- Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
- Liraglutide Effect in Atrial Fibrillation
- A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
- Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
- A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
- Semaglutide in Auto-HSCT
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
- Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- WEgovy Real World Assessment of Weight Loss in Korea
- Incretin Microdosing for Cardiometabolic Health in People With HIV
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
- Impact of Liraglutide 3.0 on Body Fat Distribution
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
- Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- Human Bioequivalence Test of Liraglutide Injection
- Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
- Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
- A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
- Treatment of Bile Acid Malabsorption With Liraglutide